Monash IVF receives improved takeover offer from Genesis Capital, Soul Patts

The news: Fertility treatment provider Monash IVF has received an improved takeover offer from longtime suitors Genesis Capital and Soul Patts.

The numbers: The indicative cash price of 90 cents per share marks an improvement from the previous bid of 80 cents per share, which was rejected by Monash in November.

Monash shares last closed at 66.5 cents each.

As of 24 November, the consortium holds a 19.6% stake in Monash.

The context: The latest proposal states that the offer price “represents the highest amount the consortium is prepared to offer as its offer price, absent a competing proposal emerging for all or a material part of Monash IVF”.

The proposal is valid until close of business on 21 April.

The Monash board is currently assessing the proposal, including taking advice from its financial adviser Macquarie Capital and legal adviser Clayton Utz.